Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

NCT05630820 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

857

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B
Hepatitis B, Chronic

Interventions

DRUG: Bepirovirsen
OTHER: Placebo

Sponsor

GlaxoSmithKline